A Carnegie Mellon Researcher Raises $35 Million For Clinical Intelligence
Carnegie Mellon spinout Xlue gains the backing of Sarah Guo’s VC firm Conviction to use AI to help identify which patients are most at risk of developing cancer.
We haven't written up this one. Forbes has the full story — the link below goes straight to it.